The estimation of microvessel density (MVD) using immunostaining of anti-CD34 antibody:
M7165
The M7165 is a high-performance microwave signal generator produced by Agilent Technologies. It is designed to generate precise and stable microwave signals across a wide frequency range. The M7165 offers a variety of features to support various applications in research, development, and testing environments.
Lab products found in correlation
14 protocols using m7165
Quantitative Assessment of Angiogenesis
Quantitative Analysis of Tumor Angiogenesis
Immunohistochemical Analysis of α-SMA and CD34
The following antibodies were used for immunohistochemistry: monoclonal mouse anti-human α-SMA (M0851, DAKO, Agilent Technologies, Inc., Santa Clara, CA, USA) and monoclonal mouse anti-human CD34 (M7165, DAKO, Agilent), both diluted 1:100. The detection system was EnVision™ FLEX+, Mouse, High pH (Link) (K8002, DAKO Cytomation, Agilent, Glostrup, Denmark). The manufacturer’s protocols were followed. Eighteen sections were used as controls.
Photomicrographs of representative immunohistochemical staining fields were obtained using an Olympus CX 21 microscope fitted with an Olympus C5050Z digital camera (Olympus Optical Co., Ltd., Tokyo, Japan).
Quantifying Angiogenesis in Cancer Models
Example 7
Tissue sections were process as described (Sukhdeo, K. et al. Proc Natl Acad Sci USA 104, 7516-21 (2007)). Sections were incubated with primary antibodies (5 μg/ml) or the corresponding IgG fraction of preimmune serum overnight at 4° C. in blocking solution (3% BSA/PBS). BCL9 (ab37305, Abcam), mouse CD34 (RAM34, eBiosciences), human CD34 (M7165, Dako) and human CD44H (2C5, R&D Systems) antibodies were employed. Blood vessel formation in the CRC and MM models was evaluated using anti-mouse CD34 and anti-human CD34 antibodies, respectively, and the corresponding biotinylated antibodies coupled to streptavidin peroxidase (Vector). The number of blood vessels was determined by counting the mean number of independent blood vessels in 5 randomly selected fields at 50× magnification as highlighted by CD34 staining (brown color). See results in
Immunohistochemical Analysis of Blood Vessels
Example 7
Tissue sections were process as described (Sukhdeo, K. et al. Proc Natl Acad Sci USA 104, 7516-21 (2007)). Sections were incubated with primary antibodies (5 μg/ml) or the corresponding IgG fraction of preimmune serum overnight at 4° C. in blocking solution (3% BSA/PBS). BCL9 (ab37305, Abcam), mouse CD34 (RAM34, eBiosciences), human CD34 (M7165, Dako) and human CD44H (2C5, R&D Systems) antibodies were employed. Blood vessel formation in the CRC and MM models was evaluated using anti-mouse CD34 and anti-human CD34 antibodies, respectively, and the corresponding biotinylated antibodies coupled to streptavidin peroxidase (Vector). The number of blood vessels was determined by counting the mean number of independent blood vessels in 5 randomly selected fields at 50× magnification as highlighted by CD34 staining (brown color). See results in
Immunofluorescence Staining of SFT/HPC Tissues
Annotating Vascular Lakes in Uveal Melanoma
For reproducibility, a VL was annotated only if it satisfied the following criteria:
A VL must contain blood and/or plasma.
Eighty percent or more of the “lake” must lack endothelial lining (
Annotators were blinded from all patient data, including patient outcome, while the digital analysis was being performed (annotations completed by HJ and SEC).
Immunohistochemical Analysis of Tumor Samples
Immunohistochemical Staining for Cell Markers
Sections of various control tissues (breast for CK7, liver for CK19, and colon for CD34) with known positivity for the target proteins were used as positive stain controls. Positive staining was defined as dark brown staining pattern. Scant or fine granular background staining or no staining at all was considered negative.
Gremlin-1 Immunohistochemistry in Aortic Tissue
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!